Up-regulation of nucleotide excision repair in mouse lung and liver following chronic exposure to aflatoxin B1 and its dependence on p53 genotype

Toxicology and Applied Pharmacology

Volumn 275, Issue 2, 2014, Pages 96-103

  Mulder, Jeanne E ^a   Bondy, Genevieve S ^b   Mehta, Rekha ^b   Massey, Thomas E ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b TOXICOLOGY RESEARCH DIVISION   (Canada)

Author keywords

Aflatoxin B1; Chronic; Nucleotide excision repair; P53 genotype

Indexed keywords

AFLATOXIN B(1); CHRONIC; NUCLEOTIDE EXCISION REPAIR; P53 GENOTYPE;

AFLATOXIN B1; ALLELES; ANIMALS; BIOTRANSFORMATION; DNA DAMAGE; DNA REPAIR; GENOTYPE; LIVER; LUNG; MALE; MICE; MICE, KNOCKOUT; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 84894077488     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.12.016     Document Type: Article

References (47)

1. Adimoolam S., Ford J.M. p53 and regulation of DNA damage recognition during nucleotide excision repair. DNA Repair (Amst) 2003, 2:947-954.
2. Alekseyev Y.O., Hamm M.L., Essigmann J.M. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo. Carcinogenesis 2004, 25:1045-1051.
3. Bedard L.L., Alessi M., Davey S., Massey T.E. Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat. Cancer Res. 2005, 65:1265-1270.
4. Brown P.J., Massey T.E. In vivo treatment with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces organ-specific alterations in in vitro repair of DNA pyridyloxobutylation. Mutat. Res. 2009, 663:15-21.
5. Chang Y.C., Jan K.Y., Cheng C.A., Liao C.B., Liu Y.C. Direct involvement of the tumor suppressor p53 in nucleotide excision repair. DNA Repair (Amst) 2008, 7:751-761.
6. Costa R.M., Chigancas V., da Silva G.R., Carvalho H., Menck C.F. The eukaryotic nucleotide excision repair pathway. Biochimie 2003, 85:1083-1099.
7. Croy R.G., Wogan G.N. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res. 1981, 41:197-203.
8. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A.J., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
9. 1 in two cases of lung cancer in man. J. Cancer Res. Clin. Oncol. 1981, 100:221-224.
10. Eaton D.L., Ramsdell H.S., Neal G.E. Biotransformation of aflatoxins. The Toxicology of Aflatoxins: Human Health, Veterinary, and Agricultural Significance 1994, 45-72. Academic Press, San Diego. D.L. Eaton, J.D. Groopman (Eds.).
11. 1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. Drug Metab. Rev. 1982, 13:581-602.
12. 1 to a reactive derivative toxic to Salmonella typhimurium TA1530. Cancer Res. 1972, 32:2058-2066.
13. Gillet L.C., Scharer O.D. Molecular mechanisms of mammalian global genome nucleotide excision repair. Chem. Rev. 2006, 106:253-276.
14. Groopman J.D., Fowler K.W., Busby W.F., Wogan G.N. Interaction of aflatoxin B2 with rat liver DNA and histones in vivo. Carcinogenesis 1981, 2:1371-1373.
15. Guindon K.A., Foley J.F., Maronpot R.R., Massey T.E. Failure of catalase to protect against aflatoxin B(1)-induced mouse lung tumorigenicity. Toxicol. Appl. Pharmacol. 2007, 227:179-183.
16. Harrison J.C., Garner R.C. Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Carcinogenesis 1991, 12:741-743.
17. Hayes R.B., Van Nieuwenhuize J.P., Raatgever J.W., ten Kate F.J.W. Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. Food Chem. Toxicol. 1984, 22:39-43.
18. Hertzog P.J., Smith J.R., Garner R.C. Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1. Carcinogenesis 1982, 3:723-725.
19. Hwang B.J., Ford J.M., Hanawalt P.C., Chu G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:424-428.
20. Jayaraman J., Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 1995, 81:1021-1029.
21. Leveillard T., Andera L., Bissonnette N., Schaeffer L., Bracco L., Egly J.M., Wasylyk B. Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations. EMBO J. 1996, 15:1615-1624.
22. Li Z., Musich P.R., Serrano M.A., Dong Z., Zou Y. XPA-mediated regulation of global nucleotide excision repair by ATR is p53-dependent and occurs primarily in S-phase. PLoS One 2011, 6:e28326.
23. Lloyd D.R., Hanawalt P.C. p53-dependent global genomic repair of benzo[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. Cancer Res. 2000, 60:517-521.
24. Lloyd D.R., Hanawalt P.C. p53 controls global nucleotide excision repair of low levels of structurally diverse benzo(g)chrysene-DNA adducts in human fibroblasts. Cancer Res. 2002, 62:5288-5294.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
26. Marietta C., Thompson L.H., Lamerdin J.E., Brooks P.J. Acetaldehyde stimulates FANCD2 monoubiquitination, H2AX phosphorylation, and BRCA1 phosphorylation in human cells in vitro: implications for alcohol-related carcinogenesis. Mutat. Res. 2009, 664:77-83.
27. 1 carcinogenicity. Proc. Soc. Exp. Biol. Med. 1995, 208:213-227.
28. Massey T.E., Smith G.B., Tam A.S. Mechanisms of aflatoxin B1 lung tumorigenesis. Exp. Lung Res. 2000, 26:673-683.
29. McGlynn K.A., Hunter K., LeVoyer T., Roush J., Wise P., Michielli R.A., Shen F.M., Evans A.A., London W.T., Buetow K.H. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003, 63:4594-4601.
30. 1 DNA adducts by the UvrABC endonuclease of Escherichia coli. J. Biol. Chem. 1993, 268:7990-8002.
31. 1: a new metabolite. Chem. Res. Toxicol. 1992, 5:333-335.
32. Rossner P., Mrhalkova A., Uhlirova K., Spatova M., Rossnerova A., Libalova H., Schmuczerova J., Milcova A., Topinka J., Sram R.J. Nucleotide excision repair is not induced in human embryonic lung fibroblasts treated with environmental pollutants. PLoS One 2013, 8:e69197.
33. Salles B., Frit P., Provot C., Jaeg J.P., Calsou P. In vitro eukaryotic DNA excision repair assays: an overview. Biochimie 1995, 77:796-802.
34. Smela M.E., Currier S.S., Bailey E.A., Essigmann J.M. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 2001, 22:535-545.
35. Smela M.E., Hamm M.L., Henderson P.T., Harris C.M., Harris T.M., Essigmann J.M. The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6655-6660.
36. Storer R.D., French J.E., Haseman J., Hajian G., LeGrand E.K., Long G.G., Mixson L.A., Ochoa R., Sagartz J.E., Soper K.A. P53+/- hemizygous knockout mouse: overview of available data. Toxicol. Pathol. 2001, 29:30-50. (Suppl.).
37. Takahashi Y., Nakatsuru Y., Zhang S., Shimizu Y., Kume H., Tanaka K., Ide F., Ishikawa T. Enhanced spontaneous and aflatoxin-induced liver tumorigenesis in xeroderma pigmentosum group A gene-deficient mice. Carcinogenesis 2002, 23:627-633.
38. Wakasugi M., Kawashima A., Morioka H., Linn S., Sancar A., Mori T., Nikaido O., Matsunaga T. DDB accumulates at DNA damage sites immediately after UV irradiation and directly stimulates nucleotide excision repair. J. Biol. Chem. 2002, 277:1637-1640.
39. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J.M., Wang Z., Freidberg E.C., Evans M.K., Taffe B.G. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet. 1995, 10:188-195.
40. Wang Q.E., Zhu Q., Wani M.A., Wani G., Chen J., Wani A.A. Tumor suppressor p53 dependent recruitment of nucleotide excision repair factors XPC and TFIIH to DNA damage. DNA Repair (Amst) 2003, 2:483-499.
41. Wani M.A., Zhu Q., El-Mahdy M., Venkatachalam S., Wani A.A. Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Res. 2000, 60:2273-2280.
42. 1. J. Natl. Cancer Inst. 1968, 40:1195-1197.
43. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 2004, 80:1106-1122.
44. Woo L.L., Egner P.A., Belanger C.L., Wattanawaraporn R., Trudel L.J., Croy R.G., Groopman J.D., Essigmann J.M., Wogan G.N., Bouhenguel J.T. Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice. Toxicol. Sci. 2011, 122:38-44.
45. Wood R.D., Robins P., Lindahl T. Complementation of the xeroderma pigmentosum DNA repair defect in cell- free extracts. Cell 1988, 53:97-106.
46. Wood R.D., Biggerstaff M., Shivji M.K.K. Detection and measurement of nucleotide excision repair synthesis by mammalian cell extracts in vitro. Methods Companion Methods Enzymol. 1995, 7:163-175.
47. Zhu Q., Wani M.A., El Mahdy M., Wani A.A. Decreased DNA repair efficiency by loss or disruption of p53 function preferentially affects removal of cyclobutane pyrimidine dimers from non-transcribed strand and slow repair sites in transcribed strand. J. Biol. Chem. 2000, 275:11492-11497.